224 related articles for article (PubMed ID: 37499908)
1. An artificial intelligence-assisted physiologically-based pharmacokinetic model to predict nanoparticle delivery to tumors in mice.
Chou WC; Chen Q; Yuan L; Cheng YH; He C; Monteiro-Riviere NA; Riviere JE; Lin Z
J Control Release; 2023 Sep; 361():53-63. PubMed ID: 37499908
[TBL] [Abstract][Full Text] [Related]
2. Predicting Nanoparticle Delivery to Tumors Using Machine Learning and Artificial Intelligence Approaches.
Lin Z; Chou WC; Cheng YH; He C; Monteiro-Riviere NA; Riviere JE
Int J Nanomedicine; 2022; 17():1365-1379. PubMed ID: 35360005
[TBL] [Abstract][Full Text] [Related]
3. Machine learning and artificial intelligence in physiologically based pharmacokinetic modeling.
Chou WC; Lin Z
Toxicol Sci; 2023 Jan; 191(1):1-14. PubMed ID: 36156156
[TBL] [Abstract][Full Text] [Related]
4. Development of a multi-route physiologically based pharmacokinetic (PBPK) model for nanomaterials: a comparison between a traditional versus a new route-specific approach using gold nanoparticles in rats.
Chou WC; Cheng YH; Riviere JE; Monteiro-Riviere NA; Kreyling WG; Lin Z
Part Fibre Toxicol; 2022 Jul; 19(1):47. PubMed ID: 35804418
[TBL] [Abstract][Full Text] [Related]
5. Artificial intelligence and machine learning disciplines with the potential to improve the nanotoxicology and nanomedicine fields: a comprehensive review.
Singh AV; Varma M; Laux P; Choudhary S; Datusalia AK; Gupta N; Luch A; Gandhi A; Kulkarni P; Nath B
Arch Toxicol; 2023 Apr; 97(4):963-979. PubMed ID: 36878992
[TBL] [Abstract][Full Text] [Related]
6. Artificial Intelligence and Machine Learning in Computational Nanotoxicology: Unlocking and Empowering Nanomedicine.
Singh AV; Ansari MHD; Rosenkranz D; Maharjan RS; Kriegel FL; Gandhi K; Kanase A; Singh R; Laux P; Luch A
Adv Healthc Mater; 2020 Sep; 9(17):e1901862. PubMed ID: 32627972
[TBL] [Abstract][Full Text] [Related]
7. A physiologically based pharmacokinetic model to predict pegylated liposomal doxorubicin disposition in rats and human.
Montanha MC; Howarth A; Mohamed DA; Loier E; Main L; Rösslein M; Delmaar C; Prina-Mello A; Siccardi M
Drug Deliv Transl Res; 2022 Sep; 12(9):2178-2186. PubMed ID: 35551629
[TBL] [Abstract][Full Text] [Related]
8. Meta-Analysis of Nanoparticle Delivery to Tumors Using a Physiologically Based Pharmacokinetic Modeling and Simulation Approach.
Cheng YH; He C; Riviere JE; Monteiro-Riviere NA; Lin Z
ACS Nano; 2020 Mar; 14(3):3075-3095. PubMed ID: 32078303
[TBL] [Abstract][Full Text] [Related]
9. Interpretable XGBoost-SHAP Model Predicts Nanoparticles Delivery Efficiency Based on Tumor Genomic Mutations and Nanoparticle Properties.
Ma X; Tang Y; Wang C; Li Y; Zhang J; Luo Y; Xu Z; Wu F; Wang S
ACS Appl Bio Mater; 2023 Oct; 6(10):4326-4335. PubMed ID: 37683105
[TBL] [Abstract][Full Text] [Related]
10. Physiologically based pharmacokinetic modeling of PLGA nanoparticles with varied mPEG content.
Li M; Panagi Z; Avgoustakis K; Reineke J
Int J Nanomedicine; 2012; 7():1345-56. PubMed ID: 22419876
[TBL] [Abstract][Full Text] [Related]
11. Investigating pharmacokinetic profiles of
Pumkathin S; Hanlumyuang Y; Wattanathana W; Laomettachit T; Liangruksa M
J Biopharm Stat; 2024 Jun; ():1-16. PubMed ID: 38860461
[TBL] [Abstract][Full Text] [Related]
12. Predicting pharmacodynamic effects through early drug discovery with artificial intelligence-physiologically based pharmacokinetic (AI-PBPK) modelling.
Wu K; Li X; Zhou Z; Zhao Y; Su M; Cheng Z; Wu X; Huang Z; Jin X; Li J; Zhang M; Liu J; Liu B
Front Pharmacol; 2024; 15():1330855. PubMed ID: 38434709
[TBL] [Abstract][Full Text] [Related]
13. Toward a general physiologically-based pharmacokinetic model for intravenously injected nanoparticles.
Carlander U; Li D; Jolliet O; Emond C; Johanson G
Int J Nanomedicine; 2016; 11():625-40. PubMed ID: 26929620
[TBL] [Abstract][Full Text] [Related]
14. Machine Learning and Artificial Intelligence in Toxicological Sciences.
Lin Z; Chou WC
Toxicol Sci; 2022 Aug; 189(1):7-19. PubMed ID: 35861448
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticle biodistribution coefficients: A quantitative approach for understanding the tissue distribution of nanoparticles.
Kumar M; Kulkarni P; Liu S; Chemuturi N; Shah DK
Adv Drug Deliv Rev; 2023 Mar; 194():114708. PubMed ID: 36682420
[TBL] [Abstract][Full Text] [Related]
16. The Role of
Jayasinghe MK; Lee CY; Tran TTT; Tan R; Chew SM; Yeo BZJ; Loh WX; Pirisinu M; Le MTN
Front Digit Health; 2022; 4():838590. PubMed ID: 35373184
[TBL] [Abstract][Full Text] [Related]
17. Endocytosis mechanism in physiologically-based pharmacokinetic modeling of nanoparticles.
Deng L; Liu H; Ma Y; Miao Y; Fu X; Deng Q
Toxicol Appl Pharmacol; 2019 Dec; 384():114765. PubMed ID: 31669777
[TBL] [Abstract][Full Text] [Related]
18. Deep convolutional neural network and IoT technology for healthcare.
Wassan S; Dongyan H; Suhail B; Jhanjhi NZ; Xiao G; Ahmed S; Murugesan RK
Digit Health; 2024; 10():20552076231220123. PubMed ID: 38250147
[TBL] [Abstract][Full Text] [Related]
19.
Isoherranen N
Drug Metab Dispos; 2024 Feb; ():. PubMed ID: 38326033
[TBL] [Abstract][Full Text] [Related]
20. Physiologically based pharmacokinetic modeling of (18)F-SiFAlin-Asp3-PEG1-TATE in AR42J tumor bearing mice.
Maaß C; Rivas JR; Attarwala AA; Hardiansyah D; Niedermoser S; Litau S; Wängler C; Wängler B; Glatting G
Nucl Med Biol; 2016 Apr; 43(4):243-6. PubMed ID: 27067044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
